Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 10—October 2011
Research

Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia

Alexander E. Platonov, Ludmila S. Karan, Nadezhda M. Kolyasnikova, Natalya A. Makhneva, Marina G. Toporkova, Victor V. Maleev, Durland Fish, and Peter J. KrauseComments to Author 

Author affiliations: Central Research Institute of Epidemiology, Moscow, Russia (A.E. Platonov, L.S. Karan, N.M. Kolyasnikova, V.V. Maleev); Municipal Clinical Hospital No. 33, Yekaterinburg, Russia (N.A. Makhneva, M.G. Toporkova); Yale School of Public Health and Yale School of Medicine, New Haven, Connecticut, USA (D. Fish, P.J. Krause)

Main Article

Table 2

Patient characteristics and infection timeline for Borrelia spp. infections, by species*

Borrelia species No. patients infected Infection timeline, median no. days (IQR)
Patient characteristics
Tick bite to symptom onset Symptom onset to hospital admission
Median age, y (range) Male sex, no. (%)
B. miyamotoi 46 54 (21–77) 24 (52) 15 (12–16) 1 (1–2)
B. garinii 21 58 (18–87) 11 (52) 10 (7–13)† 5 (2–9)†
B. burgdorferi 92 50 (14–79) 49 (53) NA NA

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

*IQR, interquartile range; NA, not available.
†p<0.001 in comparison with patients with B. miyamotoi infection.

Main Article

Page created: September 20, 2011
Page updated: September 20, 2011
Page reviewed: September 20, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external